Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Expected to Announce Quarterly Sales of $78.95 Million
Equities research analysts forecast that Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Rating) will post sales of $78.95 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Collegium Pharmaceutical’s earnings. The lowest sales estimate is $75.10 million and the highest is $83.27 million. Collegium Pharmaceutical posted sales of $87.72 […]